Duopharma Biotech (Malaysia) Price on September 4, 2024
| 7148 Stock | 1.25 0.01 0.81% |
If you're considering investing in Duopharma Stock, it is important to understand the factors that can impact its price. As of today, the current price of Duopharma Biotech stands at 1.25, as last reported on the 26th of November, with the highest price reaching 1.25 and the lowest price hitting 1.23 during the day. As of now, Duopharma Stock is very risky. Duopharma Biotech Bhd secures Sharpe Ratio (or Efficiency) of 0.0394, which denotes the company had a 0.0394% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Duopharma Biotech Bhd, which you can use to evaluate the volatility of the firm. Please confirm Duopharma Biotech's Mean Deviation of 1.07, coefficient of variation of 4339.52, and Downside Deviation of 1.81 to check if the risk estimate we provide is consistent with the expected return of 0.0662%.
Duopharma Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Duopharma |
Sharpe Ratio = 0.0394
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | 7148 | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.68 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Duopharma Biotech is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Duopharma Biotech by adding it to a well-diversified portfolio.
Duopharma Biotech Valuation on September 4, 2024
It is possible to determine the worth of Duopharma Biotech on a given historical date. On September 4, 2024 Duopharma was worth 1.19 at the beginning of the trading date compared to the closed value of 1.18. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Duopharma Biotech stock. Still, in general, we apply an absolute valuation method to find Duopharma Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Duopharma Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Duopharma Biotech's related companies.
| Open | High | Low | Close | Volume | |
| 1.22 | 1.23 | 1.19 | 1.20 | 1,395,700 | |
09/04/2024 | 1.19 | 1.20 | 1.16 | 1.18 | 699,000 |
| 1.18 | 1.19 | 1.16 | 1.18 | 709,900 |
| Backtest Duopharma Biotech | | | Duopharma Biotech History | | | Duopharma Biotech Valuation | Previous | Next |
Duopharma Biotech Trading Date Momentum on September 4, 2024
| On September 05 2024 Duopharma Biotech Bhd was traded for 1.18 at the closing time. The highest price during the trading period was 1.19 and the lowest recorded bid was listed for 1.16 . The volume for the day was 709.9 K. This history from September 5, 2024 did not affect price variability. The overall trading delta to the current price is 0.00% . |
Duopharma Biotech Bhd Fundamentals Correlations and Trends
By evaluating Duopharma Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Duopharma Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Duopharma financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Duopharma Biotech Stock history
Duopharma Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Duopharma is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Duopharma Biotech Bhd will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Duopharma Biotech stock prices may prove useful in developing a viable investing in Duopharma Biotech
Duopharma Biotech Stock Technical Analysis
Duopharma Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Duopharma Biotech Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Duopharma Biotech Bhd cannot be verified against its exchange. Please verify the symbol is currently traded on Kuala Lumpur Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Duopharma Biotech November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Duopharma Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Duopharma Biotech shares will generate the highest return on investment. By undertsting and applying Duopharma Biotech stock market strength indicators, traders can identify Duopharma Biotech Bhd entry and exit signals to maximize returns
Duopharma Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Duopharma Biotech's price direction in advance. Along with the technical and fundamental analysis of Duopharma Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Duopharma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.023 | |||
| Jensen Alpha | 0.043 | |||
| Total Risk Alpha | (0.23) | |||
| Sortino Ratio | (0.05) | |||
| Treynor Ratio | (0.22) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Duopharma Stock
Duopharma Biotech financial ratios help investors to determine whether Duopharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Duopharma with respect to the benefits of owning Duopharma Biotech security.